Gut health boost: could probiotics help diabetic kidneys?
NCT ID NCT05674981
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a probiotic supplement containing two live bacteria strains could help people with diabetic kidney disease. Fifty adults with type 2 diabetes and early-stage kidney problems took either the probiotic or a placebo daily for 6 months. Researchers measured changes in kidney function and blood sugar levels to see if the probiotics could slow disease progression.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Probiotic supplement containing Lactobacillus reuteri ADR-1 and Lactobacillus rhamnosus GM-020
- What this could lead to
- If it works, this could point toward a simple, safe way to help manage diabetic kidney disease by improving gut health.
- What could go wrong
- This is a small, early-stage trial with only 50 participants. The results may not apply to everyone, and the benefit might be small or not clinically meaningful.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC KIDNEY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Chung Shan Medical University Hospital
Taichung, Taiwan, 402, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Blood test may predict rapid kidney decline in diabetes
- Blood test could flag rapid kidney failure risk in diabetes
- Blood test could predict who faces rapid kidney decline in diabetes
- Blood test may predict kidney decline in diabetes — a large trial investigates
- Could your blood type predict kidney treatment success?
- One infusion, two targets: a uric-acid-lowering drug takes aim at heart and kidney disease in youth-onset diabetes